Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Kamada

CTech 24/7

  • "A pension is no longer enough, you also need a savings policy or a provident fund for investment"
  • Ronen Agassi: "The entire insurance industry has stepped up in terms of profitability"
  • Are AI tools making us smarter or just lazier?
  • Nothing Phone 3 review: Stylish, capable, but not quite a flagship
More stories in CTech

Kamada

4 stories about Kamada
  • Workers at a Kamada lab. Photo: Kamada

    Israeli company Kamada to offer antibody treatment to Covid-19 patients

    17.06.20|Hagar Ravet“To the best of our knowledge, Kamada is the first company globally to complete manufacturing of a plasma-derived IgG product for the treatment of Covid-19,” says CEO of the Nasdaq listed company

  • Kamada CEO Amir London. Photo: Nati Levi

    FIMI Makes $25 Million Private Placement in Biomed Company Kamada

    22.01.20|Tzally GreenbergIsrael-based private equity fund FIMI became the largest shareholder in Nasdaq and Tel Aviv-listed Kamada in November

  • Kamada's facility, Israel. Photo: PR

    FIMI Becomes Biggest Shareholder in Biomed Company Kamada

    24.11.19|Golan Hazani and Tzally GreenbergNasdaq and Tel Aviv-listed Kamada develops protein-based pharmaceuticals for genetic disorders, as well as rabies antibodies and a serum against snake bites

  • Kamada CEO Amir London

    Developer Of Anti-Rabies Drug Jumps on FDA Approval

    27.08.17|Dror ReichThe plasma-derived drug is used together with the rabies vaccine to treat unvaccinated persons exposed to the virus

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive